New England Journal of Medicine
June 11, 2020 Vol. 382 No. 24
The Vaccines for Children Program at 25 — Access, Affordability, and Sustainability
Jason L. Schwartz, Ph.D., and James Colgrove, Ph.D., M.P.H.
The success of the Vaccines for Children program has meant that vaccine costs are seldom a major obstacle to childhood-vaccination efforts. But the program’s financial sustainability and the implications of its growth for other public health priorities are key issues.